Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex molecules. 1994

P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
Bone Marrow Transplantation Program, Stanford University School of Medicine, CA.

Graft-versus-host disease across minor histocompatibility barriers was induced in two different models by transplanting allogeneic bone marrow and spleen cells into irradiated H-2-compatible recipient mice. In this report, we show that administration of peptides with high binding affinity for the respective class II major histocompatibility complex molecules after transplantation is capable of preventing the development of graft-versus-host disease in two different murine models. The peptides used were myelin basic protein residues 1 through 11 with alanine at position 4 (Ac 1-11[4A]) for I-Au (A alpha uA beta u), and the antigenic core sequence 323 through 339 of ovalbumin with lysine and methionine extension (KM core) for I-As (A alpha sA beta s). In both systems, the mechanism of prevention was found to be major histocompatibility complex-associated, because nonbinding control peptides did not have any effect. Engraftment of allogeneic bone marrow cells was shown by polymerase chain reaction analysis of DNA polymorphisms in a microsatellite region within the murine interleukin-5 gene.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010047 Ovalbumin An albumin obtained from the white of eggs. It is a member of the serpin superfamily. Serpin B14
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D012091 Repetitive Sequences, Nucleic Acid Sequences of DNA or RNA that occur in multiple copies. There are several types: INTERSPERSED REPETITIVE SEQUENCES are copies of transposable elements (DNA TRANSPOSABLE ELEMENTS or RETROELEMENTS) dispersed throughout the genome. TERMINAL REPEAT SEQUENCES flank both ends of another sequence, for example, the long terminal repeats (LTRs) on RETROVIRUSES. Variations may be direct repeats, those occurring in the same direction, or inverted repeats, those opposite to each other in direction. TANDEM REPEAT SEQUENCES are copies which lie adjacent to each other, direct or inverted (INVERTED REPEAT SEQUENCES). DNA Repetitious Region,Direct Repeat,Genes, Selfish,Nucleic Acid Repetitive Sequences,Repetitive Region,Selfish DNA,Selfish Genes,DNA, Selfish,Repetitious Region, DNA,Repetitive Sequence,DNA Repetitious Regions,DNAs, Selfish,Direct Repeats,Gene, Selfish,Repeat, Direct,Repeats, Direct,Repetitious Regions, DNA,Repetitive Regions,Repetitive Sequences,Selfish DNAs,Selfish Gene
D004676 Myelin Basic Protein An abundant cytosolic protein that plays a critical role in the structure of multilamellar myelin. Myelin basic protein binds to the cytosolic sides of myelin cell membranes and causes a tight adhesion between opposing cell membranes. Golli-MBP1 Protein,Golli-MBP2 Protein,HOG5 Protein,HOG7 Protein,MBP1 Protein,MBP2 Protein,MBP3 Protein,MBP4 Protein,Myelin Basic Protein, 17.2 kDa Isoform,Myelin Basic Protein, 18.5 kDa Isoform,Myelin Basic Protein, 20.2 kDa Isoform,Myelin Basic Protein, 21.5 kDa Isoform,Myelin Basic Protein, Isoform 1,Myelin Basic Protein, Isoform 2,Myelin Basic Protein, Isoform 3,Myelin Basic Protein, Isoform 4,Myelin Basic Protein, Isoform 5,Myelin Basic Protein, Isoform 6,Myelin Basic Protein, Isoform 7,Golli MBP1 Protein,Golli MBP2 Protein
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006183 H-2 Antigens The major group of transplantation antigens in the mouse. H2 Antigens,Antigens, H-2,Antigens, H2,H 2 Antigens
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
August 1998, Proceedings of the National Academy of Sciences of the United States of America,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
May 1994, Proceedings of the National Academy of Sciences of the United States of America,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
February 1991, The Journal of experimental medicine,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
March 1990, Proceedings of the National Academy of Sciences of the United States of America,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
September 1996, Leukemia & lymphoma,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
January 1996, Molecular immunology,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
September 1991, Proceedings of the National Academy of Sciences of the United States of America,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
January 1993, Chemical immunology,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
January 2013, Blood reviews,
P G Schlegel, and R Aharoni, and D E Smilek, and L P Fernandez, and H O McDevitt, and N Tran, and M Vaysburd, and N J Chao
May 1990, The Journal of experimental medicine,
Copied contents to your clipboard!